POZEN Inc. has acquired Tribute Pharmaceuticals Canada Inc., a Canadian specialty pharmaceutical company, in a transaction valued at approximately $146 million. Upon completion of the acquisition, which is expected to occur in the fourth quarter of 2015, the combined company will be named Aralez Pharmaceuticals plc and headquartered in Ireland. The acquisition will create a premier specialty pharmaceutical company with a broad portfolio of commercial products and a growth plan focused on inno...